These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 19705965)

  • 1. Recent advances and future directions in amphiphilic cyclodextrin nanoparticles.
    Bilensoy E; Hincal AA
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1161-73. PubMed ID: 19705965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.
    Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S
    Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amphiphilic cyclodextrins and their applications. Preparation of nanoparticles based on amphiphilic cyclodextrins for biomedical applications].
    Parrot-Lopez H; Perret F; Bertino-Ghera B
    Ann Pharm Fr; 2010 Jan; 68(1):12-26. PubMed ID: 20176159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery.
    Bilensoy E; Gürkaynak O; Doğan AL; Hincal AA
    Int J Pharm; 2008 Jan; 347(1-2):163-70. PubMed ID: 17689901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilayer vesicles of amphiphilic cyclodextrins: host membranes that recognize guest molecules.
    Falvey P; Lim CW; Darcy R; Revermann T; Karst U; Giesbers M; Marcelis AT; Lazar A; Coleman AW; Reinhoudt DN; Ravoo BJ
    Chemistry; 2005 Feb; 11(4):1171-80. PubMed ID: 15619722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic evaluation of injectable cyclodextrin nanoparticles.
    Memisoglu-Bilensoy E; Doğan AL; Hincal AA
    J Pharm Pharmacol; 2006 May; 58(5):585-9. PubMed ID: 16640826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir.
    Ghera BB; Perret F; Chevalier Y; Parrot-Lopez H
    Int J Pharm; 2009 Jun; 375(1-2):155-62. PubMed ID: 19481701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications.
    Lakkakula JR; Maçedo Krause RW
    Nanomedicine (Lond); 2014 May; 9(6):877-94. PubMed ID: 24981652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interactions between cyclodextrins and triglycerides: from emulsion stabilisation to the emergence of a new drug delivery system called "beads"].
    Hamoudi M; Trichard L; Grossiord JL; Chaminade P; Duchêne D; Le Bas G; Fattal E; Bochot A
    Ann Pharm Fr; 2009 Nov; 67(6):391-8. PubMed ID: 19900602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembled cyclodextrin aggregates and nanoparticles.
    Messner M; Kurkov SV; Jansook P; Loftsson T
    Int J Pharm; 2010 Mar; 387(1-2):199-208. PubMed ID: 19963052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclodextrins in drug delivery.
    Loftsson T; Jarho P; Másson M; Järvinen T
    Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphiphilic Cyclodextrin Derivatives for Targeted Drug Delivery to Tumors.
    Erdogar N; Varan G; Bilensoy E
    Curr Top Med Chem; 2017; 17(13):1521-1528. PubMed ID: 28017158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New challenges for pharmaceutical formulations and drug delivery systems characterization using isothermal titration calorimetry.
    Bouchemal K
    Drug Discov Today; 2008 Nov; 13(21-22):960-72. PubMed ID: 18617012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclodextrins as pharmaceutical solubilizers.
    Brewster ME; Loftsson T
    Adv Drug Deliv Rev; 2007 Jul; 59(7):645-66. PubMed ID: 17601630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of aqueous solubility of fenretinide and other hydrophobic anti-tumor drugs by complexation with amphiphilic dextrins.
    Orienti I; Zuccari G; Carosio R; Montaldo PG
    Drug Deliv; 2009 Oct; 16(7):389-98. PubMed ID: 19624248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update for nurse anesthetists--part 3--cyclodextrin introduction to anesthesia practice: form, function, and application.
    Welliver M
    AANA J; 2007 Aug; 75(4):289-96. PubMed ID: 17711159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of glycol chitosan nanoparticles as carrier for low water soluble drugs.
    Trapani A; Sitterberg J; Bakowsky U; Kissel T
    Int J Pharm; 2009 Jun; 375(1-2):97-106. PubMed ID: 19481695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals.
    Thompson DO
    Crit Rev Ther Drug Carrier Syst; 1997; 14(1):1-104. PubMed ID: 9043816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclodextrin based nanosponges for pharmaceutical use: a review.
    Tejashri G; Amrita B; Darshana J
    Acta Pharm; 2013 Sep; 63(3):335-58. PubMed ID: 24152895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in developing amphiphilic cyclodextrin-based nanodevices for drug delivery.
    Yaméogo JB; Géze A; Choisnard L; Putaux JL; Semdé R; Wouessidjewe D
    Curr Top Med Chem; 2014; 14(4):526-41. PubMed ID: 24354667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.